Clear Cell Ovarian Cancer: Optimum Management and Prognosis Remain Hazy

Gynecol Oncol. 2017 Nov;147(2):237-239. doi: 10.1016/j.ygyno.2017.10.012.

Authors

John K Chan¹, Daniel S Kapp²

Affiliations

¹ California Pacific, Palo Alto Medical Foundation, Sutter Research Institute, San Francisco, CA. Electronic address: chanjohn@sutterhealth.org.
² Department of Radiation Oncology Stanford University School of Medicine, Stanford, CA, USA.

PMID: 29096823
DOI: 10.1016/j.ygyno.2017.10.012

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Ovarian Neoplasms*